Abstract
Introduction

Counteracting cell proliferation by apoptotic cell death is indispensable to maintain tissue homeostasis. Apoptosis also eliminates superfluous cells during developmental tissue-and organ sculpting, as well as damaged and/or mutated cells. The signalling networks of apoptosis are subject to complex regulation by an interplay of pro-and anti-apoptotic signalling molecules. In healthy cells, anti-apoptotic proteins provide a tolerance threshold to mild apoptotic stress and thereby prevent excessive, unwanted cell death. This tolerance is particularly pronounced in long-lived, highly specialized post-mitotic cells such as neurons, cardiomyocytes or skeletal muscle cells. However, up-regulation or over-activation of anti-apoptotic proteins can render cells insensitive to physiological cell death signals, thereby contributing to the development of cancer. The protein apoptosis repressor with caspase recruitment domain (ARC) was first described more than a decade ago [1] and was independently identified as muscle-enriched cytoplasmic protein in a later study [2]. In various signalling pathways leading to apoptosis, ARC is believed to exert its function through multiple protein-protein interactions and was also shown to be subject to significant transcriptional and post-translational regulation.
Here, we structure the disparate published knowledge on ARC and discuss the functions of ARC in the context of cellular physiology and pathophysiology. 
ARC identification and tissue-specific expression
ARC was identified by Koseki These patterns largely correspond to protein expression levels, with high ARC levels having been reported in human heart and skeletal muscle tissue, but also reported in brain samples and primary granulosa cells [6] [7] [8] [9] [10] . In mice, ARC was found in heart, skeletal muscle, diaphragm and brain tissue [4, 7, 11] , while only residual amounts could be detected in kidney samples [12] . Likewise, ARC is highly expressed in rat heart and skeletal muscle as well as in brain tissue, vascular smooth muscle and adrenal gland [9, [13] [14] [15] [16] , but not in liver, spleen or lung [13, 15, 17] . [18, 19] . From the outset this strengthened the notion that ARC could be involved in modulating apoptosis signalling by interaction with caspases or adaptor proteins. Indeed it was shown that ARC can bind to procaspases-8 and, at least in overexpression scenarios, to procaspase-2 by CARD interaction [1, 11] . ARC can also bind to itself via the CARD, with the dimer largely losing its anti-apoptotic potential [11] .
The molecular structure of ARC
The P/E rich region comprises the last 110 aa of human ARC and is highly acidic [2] . The P/E rich region can bind considerable amounts of calcium, which was shown to negatively regulate the interaction with procaspase-8 [20] . The interaction with procaspase-8 is further modulated by phosphorylation at threonine 149 within the P/E rich region: Phosphorylation by protein kinase CK2 is a requirement for ARC to bind procaspase-8 and apparently also to associate with the outer mitochondrial membrane [14, 21] 
The P/E rich region likewise presents with a high sequence similarity. (C) Domain organization of ARC. ARC comprises an NH2-terminal CARD, followed by a region rich in proline and glutamate (P/E).
12 aa deletion in the P/E rich region [9, 15, 17] . Whether this deletion has a functional consequence is however not known [17] [7] . ARC-deficient mice exert normal cardiac function when resting. However, under conditions of cardiovascular ischemia or pressure overload, significantly accelerated cardiomyopathy was observed in these animals. Cardiomyopathy was associated with increased numbers of apoptotic cardiomyocytes, highlighting a physiological role for ARC in elevating the apoptosis resistance of heart muscle cells [7] . Indeed, the cardio-specific overexpression of ARC in mice results in increased heart sizes due to surplus cells and significantly improves contractile recovery during reperfusion [12] . In line with this finding, ARC overexpressing cardiomyocytes were also found to be more resistant to apoptosis signalling induced by calcium overload and hypoxic stress in an in vitro model of ischaemia [12] . An increased apoptosis resistance of post-mitotic myocytes can also be achieved by exercise training: Both x-linked inhibitor of apoptosis protein (XIAP) and ARC protein levels in the rat soleus and heart muscles increase with intensive training [25] . In contrast to the transcriptional up-regulation of XIAP, elevated ARC protein levels seem to be established by protein stabilization rather than increased gene transcription. Significantly reduced ARC protein levels were detected in heart, aorta and skeletal muscle of hypertensive rats, and the reduction in ARC expression correlated with increased apoptosis of skeletal muscle tissues when compared to samples from normotensive rats [16, 26, 27] [7] . Importantly, ARC mRNA levels were not affected in this scenario, indicating that ARC protein destabilization rather than a down-regulation of gene transcription contributes to increased cell death susceptibility of human cardiac tissue [7] . ARC levels were also shown to drop following hypoxia/reoxygenation in cultured rat cardiomyocytes, a loss which can, however, be counteracted by repeated short post-conditioning cycles of hypoxia/ reoxygenation [28] . Interestingly, a recent study conducted in rabbits suggested that endogenous levels of oestrogen mediate a constitutively higher ARC expression in the heart tissue of female individuals, which confers elevated apoptosis resistance in response to ischaemia/reperfusion and might explain the enhanced myocardial recovery of female individuals [29] .
Physiological role and expression of ARC in brain tissue
Low levels of ARC protein were reported to be present in brain tissue samples from human, rat and mouse [6, 7, 9, 30, 31] . Even though ARC deficiency does not result in behavioural or brain histological differences in mice [7] , ARC was suggested to mediate neuronal cell death resistance. In particular it was found that with increasing age, ARC expression levels in the mouse cortex might decline [30] . This loss in ARC could be abrogated by keeping mice on calorie restricted diets. A similar effect of calorie restriction on ARC protein abundance was also reported in skeletal muscle tissue of male rats [32] . It was furthermore shown in mouse models that chronic alcohol intake reduces ARC expression in cerebellar tissue and that this loss in ARC expression might be linked with alcohol intake-associated increases in apoptotic cell death in the cerebellum [31] . Because many of the above observations were made in experimentally rather minimalistic studies, more comprehensive and functional data are required to unequivocally answer whether ARC plays a physiological role in preventing apoptosis in brain tissues. [33] . Similarly, ARC levels were shown to selectively increase in the cytosols of colon cancer tissues [8] . In contrast, subcellular fractionation in human HCT-116, MD-BM-231 and MIA PaCa-2 cancer cell lines indicated a higher abundance of ARC in the nuclei [9] . Likewise, ARC was reported to be enriched in the nuclear fraction of PC12 rat pheochromocytoma cells [15] , while in human melanoma cell lines ARC was found predominantly in the cytosol or at mitochondria [34] . Endogenous ARC in rat H9c2 cells resides largely in the soluble cytosolic fraction, whereas ectopically overexpressed ARC tended to associate with membranes [13] . Even when taking into account that the immunofluorescence or subcellular fractionation analyses employed in some of these studies suffered from limited resolution, lacked counter-stains or specificity controls, no consistent picture of ARC distribution patterns has emerged yet.
ARC expression and localization in cancer
However, besides cytosolic interactions with apoptosis regulating proteins, an additional role of ARC in the nucleus has been described (see below). This nuclear function of ARC might therefore explain differential subcellular distribution patterns of ARC.
Regulation of ARC protein levels by gene transcription and protein degradation
In tissues or cells presenting with ARC expression, little is known about the regulation of ARC transcription. It was recently shown that activated N-Ras and H-Ras can drive ARC expression, with the promoter being activated in a mitogen-activated protein kinase kinase (MEK)/extracellular-signal-regulated kinase (ERK)-dependant manner [35]. ARC expression in cancer cells correlated with Ras expression, and Ras expression was sufficient to drive ARC expression in otherwise ARC
-epithelial cells [35] . [24] . This finding thus highlighted that ARC can also exert an important anti-apoptotic function within the nucleus. [22] , and an ARC triple mutant that cannot be ubiquitylated (K17R, K68R, K163R) correspondingly shows increased stability and enhanced anti-apoptotic potential [23] . Because Mdm2 also regulates the ubiquitylation and degradation of p53 [38, 39] , ARC expression and degradation therefore are tightly interlinked with the p53/Mdm2 interplay. In addition to the role of active Ras in driving ARC expression, Ras was also shown to impair the ubiquitylation and proteasomal degradation of endogenous ARC [35] . This mode of ARC stabilization however seems independent of Mdm2 because concomitant changes in Mdm2 levels were not observed [35] . ARC can be posttranslationally stabilized in rats subjected to exercise training [25] , and ARC protein levels drop in response to hypoxia/ischaemia and oxidative stress in rat H9c2 cells as well as human HeLa and MCF-7 cancer cells, without mRNA levels being affected [22, 23] . These studies therefore indicate that modulations in ARC stability and degradation are physiologically relevant. The regulation of ARC expression and degradation is summarized and visualized in Figure 2 . (Fig. 3) . [1, 20] [11] . These associations relied on the ARC CARD, which interacted with the death domain of [45] . Apoptosis in response to broad spectrum kinase inhibitor staurosporine is believed to be at least partially dependent on the inhibition of Bad phosphorylation [51] . However, ARC overexpression is not able to inhibit or reduce staurosporineinduced apoptosis in human Jurkat cells [20] . Puma is thought to be capable of both directly activating Bax/Bak as well as antagonizing anti-apoptotic Bcl-2 family members. Puma is a major transducer of p53-dependent apoptosis in response to genotoxic stress as was shown in response to various DNA-damaging chemotherapeutics as well as ␥ irradiation [37] . ARC indeed was shown to protect rat cardiomyocytes, human HeLa cervical and SGC-7901 gastric cancer cells from apoptosis induced by doxorubicin or ionizing radiation [52] [53] [54] and it was suggested that the doxorubicin resistance is directly dependent on the ARC-Puma interaction [54] . However, ARC overexpression in Jurkat cells did not protect from etoposide-induced apoptosis [20] . Taken [11] . Physiological expression of ARC in rat H9c2 cardiomyocytes was required to prevent spontaneous Bax activation, and ectopic ARC expression could protect from apoptosis induced by Bax overexpression [11] . A direct CARD-dependent interaction of endogenous ARC with Bax was also confirmed in an independent study using H9c2 cells, where ARC provided significant protection against cell death induced by ischaemia/reperfusion and hydrogen peroxide [55] . Interestingly, in vitro experiments suggested that the interaction of ARC and Bax is not direct but may require additional interaction partners to mediate ARC-Bax association [20] . It was also shown that cytosolic p53 can induce the mitochondrial apoptosis pathway by activating Bax and that Puma is required to release cytosolic p53 from Bcl-xL [56, 57] [20] . In agreement, depleting ARC expression in Mel-RM and MM200 melanoma cells by RNA interference sensitized these cells to thapsigargin-or tunicamycin-induced apoptosis [34] . As ARC expression seems elevated in most melanomas [34] , antagonizing ARC therefore might prove helpful in sensitizing these otherwise highly resistant cells to apoptosis.
Besides the transcriptional regulation of ARC, protein levels of ARC are regulated by degradation through the ubiquitin-proteasome system. In untreated cells, ARC was shown to be a rather long-lived protein with half times ranging from 16 or 35 hrs, as reported for human cancer cells such as MCF-7, HeLa or rat H9c2 cells [22, 23]. ARC is targeted for proteasomal degradation through ubiquitylation by E3-ubiquitin ligase Mdm2
Multi-functionality of ARC in apoptosis inhibition
Elevated expression of ARC was shown to inhibit various modalities of apoptotic cell death signalling, while loss of ARC conversely sensitizes to apoptosis. In the following sections we summarize the knowledge on the ARC-dependent intracellular signalling in various pathways
Extrinsic apoptosis initiation
Extrinsic apoptosis initiated via death ligands CD95L/FasL and tumour necrosis factor (TNF)-␣ can efficiently be inhibited by ARC overexpression
Concluding comments
We 
